Plain-English translation of NCT04075305 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The MOMENTUM Study is collecting detailed medical information from up to 8,000 cancer patients who are receiving treatment with an MR-Linac—a machine that combines a high-quality MRI scanner with radiation therapy equipment. This allows doctors to see the tumor in real-time while delivering radiation, potentially making treatment more precise and safer. By gathering information about how patients respond to this advanced technology, researchers hope to improve cancer treatment outcomes and reduce side effects.
Current radiation therapy can damage healthy tissue around the tumor, causing serious side effects. This new technology allows doctors to target tumors much more precisely while patients are being treated, which could improve cure rates and reduce harmful effects—but doctors need real-world evidence to understand exactly how well it works across different cancer types.
You likely qualify if…
You likely don't qualify if…
As a participant, you would continue receiving your regular cancer treatment on the MR-Linac machine as planned. The study simply collects information about your treatment, imaging scans, and how you respond—both in terms of side effects and how well the cancer responds. This happens during your routine care visits, and researchers may also ask you to participate in additional research MRI scans or provide information about your quality of life and health outcomes over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Australia
Belgium